CDAN1 Gene Anemia Dyserythropoietic Type 1A NGS Genetic DNA Test
Understanding Congenital Dyserythropoietic Anemia Type 1A
Congenital Dyserythropoietic Anemia Type 1A (CDA1A) represents a rare inherited blood disorder characterized by ineffective red blood cell production within the bone marrow. This condition stems from mutations in the CDAN1 gene, which plays a crucial role in normal erythropoiesis – the process of red blood cell formation. The CDAN1 Gene Anemia Dyserythropoietic Type 1A NGS Genetic DNA Test provides definitive molecular diagnosis through advanced next-generation sequencing technology, offering patients and healthcare providers precise genetic information essential for proper management and treatment planning.
What This Test Detects
Our comprehensive genetic analysis specifically targets the CDAN1 gene to identify pathogenic variants responsible for CDA1A. The test examines:
- Point mutations, insertions, and deletions in the CDAN1 gene coding regions
- Regulatory sequences affecting gene expression
- Copy number variations impacting gene function
- Novel genetic variants with potential clinical significance
Clinical Indications and Who Should Consider Testing
This genetic test is recommended for individuals presenting with:
- Unexplained chronic anemia unresponsive to conventional treatments
- Abnormal red blood cell morphology observed in peripheral blood smears
- Family history of congenital dyserythropoietic anemia
- Iron overload complications despite normal hemoglobin levels
- Developmental abnormalities associated with CDA1A
- Previous inconclusive hematological evaluations
Key Benefits of Genetic Testing
Undergoing the CDAN1 Gene Anemia Dyserythropoietic Type 1A NGS Genetic DNA Test offers numerous advantages:
- Definitive Diagnosis: Provides conclusive molecular confirmation of CDA1A
- Personalized Treatment: Enables targeted therapeutic approaches based on genetic findings
- Family Planning: Offers crucial information for genetic counseling and reproductive decisions
- Prognostic Insights: Helps predict disease progression and potential complications
- Early Intervention: Facilitates timely management strategies to prevent complications
Understanding Your Test Results
Our comprehensive genetic report provides detailed interpretation of your CDAN1 gene analysis:
- Positive Result: Indicates presence of pathogenic CDAN1 mutations confirming CDA1A diagnosis
- Negative Result: Suggests absence of known CDAN1 mutations, though other genetic causes may require investigation
- Variant of Uncertain Significance: Identifies genetic changes requiring further clinical correlation
- Carrier Status: Determines if individuals carry one copy of mutated gene without disease manifestation
Test Pricing Information
| Test Description | Price (USD) |
|---|---|
| CDAN1 Gene Anemia Dyserythropoietic Type 1A NGS Genetic DNA Test – Discount Price | $500 |
| CDAN1 Gene Anemia Dyserythropoietic Type 1A NGS Genetic DNA Test – Regular Price | $700 |
Nationwide Testing Availability
We proudly offer comprehensive genetic testing services across the United States with convenient locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and numerous other cities. Our state-of-the-art laboratories ensure consistent, high-quality testing standards nationwide.
Take Control of Your Genetic Health Today
Don’t let uncertainty about inherited blood disorders affect your quality of life. The CDAN1 Gene Anemia Dyserythropoietic Type 1A NGS Genetic DNA Test provides the clarity needed for informed medical decisions and personalized care planning. Our genetic counselors are available to discuss your results and provide comprehensive guidance.
Ready to schedule your genetic test? Contact us today at +1(267) 388-9828 or book your appointment online. Take the first step toward definitive diagnosis and personalized treatment for congenital dyserythropoietic anemia.
